Editor’s Note, DCMS #132

This week we continue our Clinical Text focus on macrovascular disease associated with diabetes. Dr. Beaser gets into a discussion as to which patients should be on aspirin therapy and how the use of a particular ACE-inhibitor can make a significant difference in MI risk reduction.

The Homerun Slides continue to discuss the core defects of type 2 diabetes and taking the idea of Targeting Mechanisms for a Comprehensive Approach, and our Disaster Averted looks at the problems that can occur when a pediatric nurse has to give a 3 day old infant a diluted insulin shot.

This week’s Mastery In Minutes video from Dr. Arron Vinik looks at the potential problems that can occur when a TZD is added to a patient’s drug regimen and goes perfectly with the new data that was released on rosiglitizone last week.